DFG
ESPR

Delta Financial Group’s Esperion Therapeutics ESPR Stock Holding History

Delta Financial Group’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$40K Sell
23,150
-200
-0.9% -$369 0.01% 257
2024
Q4 		$51K Buy
23,350
+1,600
+7% +$3.73K 0.01% 249
2024
Q3 		$36K Sell
21,750
-1,200
-5% -$2.42K 0.01% 137
2024
Q2 		$51K Sell
22,950
-300
-1% -$706 0.02% 121
2024
Q1 		$62K Hold
23,250
– – 0.02% 233
2023
Q4 		$70K Buy
23,250
+100
+0.4% +$130 0.02% 218
2023
Q3 		$23K Hold
23,150
– – 0.01% 206
2023
Q2 		$32K Hold
23,150
– – 0.04% 85
2023
Q1 		$37K Sell
23,150
-200
-0.9% -$1.03K 0.01% 180
2022
Q4 		$137K Buy
+23,350
New +$167K 0.06% 169

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return